Cargando…
Activated Met Signalling in the Developing Mouse Heart Leads to Cardiac Disease
BACKGROUND: The Hepatocyte Growth Factor (HGF) is a pleiotropic cytokine involved in many physiological processes, including skeletal muscle, placenta and liver development. Little is known about its role and that of Met tyrosine kinase receptor in cardiac development. METHODOLOGY/PRINCIPAL FINDINGS...
Autores principales: | Leo, Christian, Sala, Valentina, Morello, Mara, Chiribiri, Amedeo, Riess, Ilan, Mancardi, Daniele, Schiaffino, Stefano, Ponzetto, Carola, Crepaldi, Tiziana |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036588/ https://www.ncbi.nlm.nih.gov/pubmed/21347410 http://dx.doi.org/10.1371/journal.pone.0014675 |
Ejemplares similares
-
A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart
por: Sala, Valentina, et al.
Publicado: (2016) -
Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes
por: Sala, Valentina, et al.
Publicado: (2015) -
HGF/Met Axis in Heart Function and Cardioprotection
por: Gallo, Simona, et al.
Publicado: (2014) -
MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor
por: Gallo, Simona, et al.
Publicado: (2022) -
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity
por: Bersani, Francesca, et al.
Publicado: (2023)